5-Amino-9-(diethylamino)benzo[a]phenoxazin-7-ium chloride

Catalog No. :
ACTVES731
CAS No. :
2381-85-3
Molecular Formula :
C20H20ClN3O
Molecular Weight :
353.85

IUPAC Name:N-(5-amino-9H-benzo[a]phenoxazin-9-ylidene)-N-ethylethanaminium chloride

5-Amino-9-(diethylamino)benzo[a]phenoxazin-7-ium chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g95%$58.00Login to see priceIn stockInquiry
100g95%$177.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Amino-9-(diethylamino)benzo[a]phenoxazin-7-ium chloride
IUPAC NameN-(5-amino-9H-benzo[a]phenoxazin-9-ylidene)-N-ethylethanaminium chloride
MDL No.MFCD00011936
Molecular FormulaC20H20ClN3O
Molecular Weight353.85
SMILES[Cl-].CC[N+](CC)=C1C=CC2=NC3=C(OC2=C1)C=C(N)C1=C3C=CC=C1
InChI KeySHXOKQKTZJXHHR-UHFFFAOYSA-N
SynonymFT-0759287 | AKOS004901433 | N-(5-amino-9H-benzo[a]phenoxazin-9-ylidene)-N-ethylethanaminium chloride | 5-Amino-9-(diethylamino)benzo(a)phenoxazin-7-ium chloride | Nile Blue chloride, Dye content 85 % | UNII-E58RL8T2X3 | Nile Blue A | NSC146184 | NSC-1461
CAS No.2381-85-3
PubChem CID16938

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P233-P260-P261-P264-P271-P280-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTVES731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTVES731 route product structure diagram
    ACTVES7312381-85-3 In Stock
Inquiry

2. ACTVES731 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTVES731 route product structure diagram
    ACTVES7312381-85-3 In Stock
Inquiry

Comments (0)